We are live on ! Find out more
Altshuler Shaham

Altshuler Shaham Portfolio holdings

AUM $8.04B Turnover 35.93%
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
–
AUM
$705M
AUM Growth
–
Cap. Flow
+$671M
Cap. Flow %
95.25%
Top 10 Hldgs %
81.76%
Holding
162
New
161
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Real Estate 42.31%
2 Industrials 14.34%
3 Miscellaneous 14.29%
4 Healthcare 11.21%
5 Consumer Discretionary 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CBAY icon
76
DELISTED
Cymabay Therapeutics
CBAY
$596K 0.08%
+64,800
New +$554K
2017 Q4
0 quarters
CAFD
77
DELISTED
8point3 Energy Partners LP
CAFD
$570K 0.08%
+41,850
New +$630K
2017 Q4
0 quarters
KYNB icon
78
Kyntra Bio
KYNB
$21.3M
$562K 0.08%
+474
New +$594K
2017 Q4
0 quarters
NICE icon
79
Nice
NICE
$6.49B
$544K 0.08%
+5,885
New +$501K
2017 Q4
0 quarters
ARQL
80
DELISTED
Arqule Inc
ARQL
$536K 0.08%
+325,000
New +$421K
2017 Q4
0 quarters
JCI icon
81
Johnson Controls International
JCI
$89.2B
$526K 0.07%
+13,814
New +$540K
2017 Q4
0 quarters
TVTX icon
82
Travere Therapeutics
TVTX
$4.76B
$520K 0.07%
+24,700
New +$565K
2017 Q4
0 quarters
TEVA icon
83
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
$506K 0.07%
+29,031
New +$437K
2017 Q4
0 quarters
CSTE icon
84
Caesarstone
CSTE
$91.3M
$467K 0.07%
+21,210
New +$544K
2017 Q4
0 quarters
POWI icon
85
Power Integrations
POWI
$2.55B
$465K 0.07%
+12,636
New +$482K
2017 Q4
0 quarters
ONCE
86
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$358K 0.05%
+6,966
New +$500K
2017 Q4
0 quarters
EVGN icon
87
Evogene
EVGN
$6.25M
$283K 0.04%
+8,673
New +$341K
2017 Q4
0 quarters
ORA icon
88
Ormat Technologies
ORA
$5.55B
$251K 0.04%
+3,921
New +$249K
2017 Q4
0 quarters
RDHL icon
89
Redhill Biopharma
RDHL
$4.45M
$251K 0.04%
+169
New +$1.14M
2017 Q4
0 quarters
ICL icon
90
ICL Group
ICL
$6.4B
$225K 0.03%
+56,725
New +$236K
2017 Q4
0 quarters
STLA icon
91
Stellantis
STLA
$12.9B
$219K 0.03%
+12,255
New +$216K
2017 Q4
0 quarters
RACE icon
92
Ferrari
RACE
$69.8B
$139K 0.02%
+1,330
New +$148K
2017 Q4
0 quarters
CEL
93
DELISTED
Cellcom Israel, Ltd.
CEL
$129K 0.02%
+12,490
New +$121K
2017 Q4
0 quarters
CRC icon
94
DELISTED
California Resources Corporation
CRC
$95K 0.01%
+4,870
New +$68.3K
2017 Q4
0 quarters
GE icon
95
CALL
GE Aerospace
GE
$328B
$80K 0.01%
+71,496
New +$6.83M
2017 Q4
0 quarters
RDS.A
96
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$68K 0.01%
+3,550
New +$224K
2017 Q4
0 quarters
BCOM icon
97
DELISTED
B Communications Ltd
BCOM
$54K 0.01%
+2,970
New +$46.3K
2017 Q4
0 quarters
CTXS
98
DELISTED
Citrix Systems Inc
CTXS
$36K 0.01%
+1,400
New +$119K
2017 Q4
0 quarters
INDP icon
99
Indaptus Therapeutics
INDP
$349M
$35K 0.01%
+4
New +$62K
2017 Q4
0 quarters
RTX icon
100
RTX Corp
RTX
$258B
$33K ﹤0.01%
+410
New +$31.1K
2017 Q4
0 quarters

Similar funds

Altshuler Shaham's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for Altshuler Shaham, which disclosed 162 positions worth $705M. Its ten largest holdings account for 82% of the portfolio.

Its largest position is Simon Property Group: 1,266,222 shares worth $217M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, followed by Industrials and Miscellaneous.

  • Altshuler Shaham's largest Q4 2017 buy was Simon Property Group: 1,266,222 shares worth $217M.
  • Altshuler Shaham's ten largest holdings make up 82% of its $705M portfolio in Q4 2017.
  • Altshuler Shaham disclosed 162 positions in Q4 2017, its first 13F filing on record.

Based on Altshuler Shaham's 13F filing for Q4 2017, filed 14 May 2018.